Skip to content

Form 4 filed by Megna Michael R

Megna Michael R filed this Form 4 on KNSA (Kiniksa Pharmaceuticals International, plc) with 15 transaction rows and 0 holding rows, accepted by EDGAR 2026-11-03 23:26:05 UTC.

Accession
0001464583-26-000010
Filed
2026-11-03
Accepted by EDGAR
Ingested
Source
EDGAR live feed

Original filing

Issuer and reporting owners

Issuer: KNSA · Kiniksa Pharmaceuticals International, plc (CIK 1730430)

Rows

SecurityDateCodeSharesPriceOwned afterOwnership
Class A Ordinary Share 2026-10-30M exercised+4,689$10.7633,751D
Class A Ordinary Share 2026-10-30M exercised+3,932$11.137,683D
Class A Ordinary Share 2026-10-30M exercised+7,209$11.9744,892D
Class A Ordinary Share 2026-10-30M exercised+4,065$17.7648,957D
Class A Ordinary Share 2026-10-30S sold-6,030$91.8742,927D
Class A Ordinary Share 2026-10-30S sold-6,831$92.7736,096D
Class A Ordinary Share 2026-10-30S sold-9,508$94.226,588D
Class A Ordinary Share 2026-10-30S sold-3,705$94.8622,883D
Class A Ordinary Share 2026-10-30S sold-3,145$96.0819,738D
Class A Ordinary Share 2026-10-30S sold-1,691$97.1118,047D
Class A Ordinary Share 2026-10-30S sold-5,350$97.7412,697D
Share Option derivative2026-10-30M exercised-3,932$00D
Share Option derivative2026-10-30M exercised-7,209$00D
Share Option derivative2026-10-30M exercised-4,689$02,983D
Share Option derivative2026-10-30M exercised-4,065$016,394D